Feeds:
Posts
Comments

Archive for the ‘biotech’ Category

This morning’s Globe story about Biogen notes that its stock has declined by about 14 percent since it hit the sale block around mid-October. All of this seems to be due to the fact that people aren’t really sure that a deal will be made for Biogen. The Globe quotes one analyst’s optimism about a [...]

Read Full Post »